Hims & Hers analyst cuts price target on downside risk to 2026 estimates

There is downside revision risk to the 2026 consensus EBITDA estimates for Hims & Hers Health Inc HIMS, with the EBITDA ...

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports ...
Hawk Central

Thinking about Hims for weight loss? Here’s what to know first

Few people consult a doctor before attempting weight loss. Hims offers virtual weight loss support for men, including consultations and prescriptions. Hims provides GLP-1 injections, meal replacements ...
Investing.com South Africa

Hims & Hers Health stock falls as insider files to sell shares

Investing.com -- Hims & Hers Health Inc (NYSE:HIMS) shares fell 5.3% Tuesday after an insider filed to sell a significant stake in the company.
Hosted on MSN

Hims & Hers plunges 29.4% in three months: How to play the stock?

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses lately. However, the stock is currently experiencing an uptrend in its price performance. The San Francisco, ...

Honest Hims hair growth review: What men should know before buying

Need a solution for your thinning hair line? We took a deep dive into Hims hair growth program to see how it works and who it ...
AOL

Analysis-Hims expansion may not come in time for risky GLP-1 business

NEW YORK, March 2 (Reuters) - Telehealth company Hims & Hers Health, known for its weight-loss drug business, is promising it can diversify away from its reliance on compounded GLP-1 sales in the U.S.
USA Today

Hims hair loss review: Cost, how it works, and who it’s good for

Traditionally, if you wanted prescription medication for weight loss, hair regrowth, or erectile dysfunction, you had to make an appointment with your doctor. Needless to say, that isn’t always a ...